FDA Inspection
Mid-America Transplant Services (dba Mid-America Transplant)Mid-America Transplant Services (dba Mid-America Transplant) – FDA Inspection, Apr 19, 2019
Record Details
This FDA Inspection record concerns Mid-America Transplant Services (dba Mid-America Transplant), with an inspection on April 19, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- April 19, 2019
- Product Type
- Biologics
View Company Profile
ID · 5173a6e2-ab2a-4d38-a974-8f22334513fa
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1089056
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Mid-America Transplant Services (dba Mid-America Transplant)
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 23, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 4, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| October 30, 2014 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 25, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| November 23, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Mid-America Transplant Services (dba Mid-America Transplant)
- FDA Inspection 1247285 - 2024-08-23
- FDA Inspection 997610 - 2017-01-04
- FDA Inspection 901726 - 2014-10-30
- FDA Inspection 841595 - 2013-07-25
- FDA Inspection 633300 - 2009-11-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.